Representing Kansas bioscience companies and research institutions
Home About KansasBio Membership Center Bioscience News Contact KansasBio
Information Resources Education & Training Networking & Collaboration Business & Investment

 

Up-to-the minute latest news in the biotechnology sector and from biotech companies in Kansas and around the world

  KansasBio photos  

Search:

Biotechnology Headlines from PR Newswire


Pacific Shore Holdings Retains Investor Relations Firm
Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria
Dr. Gerald 'Jerry' Zon Launches New Blog for TriLink BioTechnologies
Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference
For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs
American Pharmacy Magazine Article [Sponsored by Intelligent Hospital Systems] Compares i.v.STATION Robot to IHS' RIVA
Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S.
Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes
Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer
TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace
Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP)
New Release of Accelrys Electronic Lab Notebook Transforms Laboratory Operations
BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute
BioRestorative Therapies Signs Agreement with Dexterity, Inc. to Advance Production of the Company's Novel brtxDISC™ Stem Cell Therapy Device
Amarantus to Present at the 2nd Annual Marcum MicroCap Conference on May 30
Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico
Oxitec Report 96% Suppression of the Dengue Mosquito in Brazilian Trials
Intercept Pharmaceuticals Announces Positive Initial Results from Ongoing Phase 2a Trial in Chronic Bile Acid Diarrhea
eFFECTOR Therapeutics Raises $45 Million in Series A Financing
RXi Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference
Automated External Defibrillator Market worth $930 Million By 2017
Elsevier Announces Collaboration with The Geological Society of America To Add Over 60,000 Maps to Geofacets Research Tool
German Federal Joint Committee (G-BA) Issues Final Assessment Report for PIXUVRI® (pixantrone)
Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy
Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
Sony Delivers New Technology for Science to CYTO 2013
Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting
MedTech Innovate Seminars: New Interactive Learning Forums at 2013 MD&M East
Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis
Yongye International Provides Update on Status of Proposed Go Private Offer
Celsion's ThermoDox® HEAT Study Findings Reviewed at the 9th Annual World Conference on Interventional Oncology (WCIO)
Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S.
Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy
Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech
Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results
AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease
A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing
PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City
InspireMD to Announce Six-Month Results from the MGuard™ Embolic Protection Stent (EPS) MASTER Trial at EuroPCR
Amgen To Present At The UBS Global Life Sciences Conference
HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast
AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
Valtech Cardio Treats First Mitral Regurgitation Patients with Percutaneous Annuloplasty Device Without Open-Heart Surgery
BioTrinity Ventures to the Capital
ThromboGenics Business Update
Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
Medigus: Successful Three-Year Follow-Up Data of the SRS™ Pivotal Study in Indiana University Will be Presented at the Digestive Disease Week in Orlando
InspireMD Announces Reimbursement Coverage for MGuard™ Coronary Embolic Protection Stent (EPS) From Brazil's Largest Private Insurer

< Prev Next >
PR Newswire - United Business Media
 



Kansas Bioscience Association

© 2004 Kansas Bioscience Organization (KansasBio). All rights reserved.